Weiwei Wang1, Ting Jiang1, Chunyu Li1, Jun Chen1, Kejiang Cao1, Lian-Wen Qi1, Ping Li1, Wei Zhu1, Baoli Zhu1, Yan Chen1. 1. 1 Emergency Center, 2 Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China ; 3 State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China ; 4 Department of Oncology, the First Affiliated Hospital of Medical University, Nanjing 210029, China ; 5 Institute of Occupational Disease Prevention and Treatment, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing 210028, China.
Abstract
BACKGROUND: According to the present evidences suggesting association between low testosterone level and prediction of reduced exercise capacity as well as poor clinical outcome in patients with heart failure, we sought to determine if testosterone replacement therapy (TRT) improves clinical and cardiovascular conditions as well as quality of life status in patients with stable chronic heart failure (CHF). METHODS: We carried out a review based on 8 published clinical trials to determine whether TRT will benefit patients with CHF. Information of exercise capacity, hemodynamic parameters, electrocardiogram indicators, muscle strength, echocardiography guidelines and laboratory indexes were collected to assess clinical outcomes. RESULTS: We found that TRT could improve significantly exercise capacity, muscle strength and electrocardiogram indicators but no significant changes in ejection fraction (EF), systolic blood pressure (SBP), diastolic blood pressure (DBP), N-terminal pro-brain natriuretic peptide (NT-proBNP), tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6). CONCLUSIONS: High-quality studies are required to better understand the clinical effects of testosterone.
BACKGROUND: According to the present evidences suggesting association between low testosterone level and prediction of reduced exercise capacity as well as poor clinical outcome in patients with heart failure, we sought to determine if testosterone replacement therapy (TRT) improves clinical and cardiovascular conditions as well as quality of life status in patients with stable chronic heart failure (CHF). METHODS: We carried out a review based on 8 published clinical trials to determine whether TRT will benefit patients with CHF. Information of exercise capacity, hemodynamic parameters, electrocardiogram indicators, muscle strength, echocardiography guidelines and laboratory indexes were collected to assess clinical outcomes. RESULTS: We found that TRT could improve significantly exercise capacity, muscle strength and electrocardiogram indicators but no significant changes in ejection fraction (EF), systolic blood pressure (SBP), diastolic blood pressure (DBP), N-terminal pro-brain natriuretic peptide (NT-proBNP), tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6). CONCLUSIONS: High-quality studies are required to better understand the clinical effects of testosterone.
Authors: Peter J Pugh; Richard D Jones; Chris J Malkin; Joanne Hall; Joanne E Nettleship; Katherine E Kerry; T Hugh Jones; Kevin S Channer Journal: Endocr Res Date: 2005 Impact factor: 1.720
Authors: Chris J Malkin; Peter J Pugh; John N West; Edwin J R van Beek; T Hugh Jones; Kevin S Channer Journal: Eur Heart J Date: 2005-08-10 Impact factor: 29.983
Authors: Mustafa Toma; Finlay A McAlister; Erin E Coglianese; Venkatesan Vidi; Samip Vasaiwala; Jeffrey A Bakal; Paul W Armstrong; Justin A Ezekowitz Journal: Circ Heart Fail Date: 2012-04-17 Impact factor: 8.790
Authors: Martin Stout; Garry A Tew; Helen Doll; Irena Zwierska; Nicola Woodroofe; Kevin S Channer; John M Saxton Journal: Am Heart J Date: 2012-10-30 Impact factor: 4.749
Authors: Ahmad Mirdamadi; Mohammad Garakyaraghi; Ali Pourmoghaddas; Alireza Bahmani; Hamideh Mahmoudi; Mojgan Gharipour Journal: Biomed Res Int Date: 2014-07-06 Impact factor: 3.411
Authors: Andrea Salzano; Alberto M Marra; Michele Arcopinto; Roberta D'Assante; Vincenzo Triggiani; Enrico Coscioni; Daniela Pasquali; Giuseppe Rengo; Toru Suzuki; Eduardo Bossone; Antonio Cittadini Journal: ESC Heart Fail Date: 2019-11-07